A Comparison of Renal vs Limb NIRS for Predicting Cardiac Surgery Associated Acute Kidney Injury
NCT ID: NCT06705855
Last Updated: 2025-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2025-05-29
2026-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Near Infrared Spectroscopy for the Detection of Acute Kidney Injury in Children Following Cardiac Surgery
NCT01382758
RRI Compared With NephroCheckTM to Predict Acute Renal Failure After Cardiac Surgery.
NCT02325726
Noninvasive Measurements of Renal Perfusion During Cardiac Surgery
NCT03335865
Effectiveness of the NephroCheck⢠After TAVI
NCT02976792
Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized Patients
NCT05988658
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The pathophysiology of AKI after cardiac surgery is multifactorial but the profound hemodynamic changes that occur in cardiac surgery likely play an important role. The renal medulla has the highest metabolic activity and least oxygen reserve in the kidney and medullary hypoxia is thought to be a major determinant of AKI.16, 17 One major limitation in the effort to reduce the incidence of AKI is the lack of a real-time monitor of renal hypoxia. As there is no current therapy for AKI once the disease has occurred, prevention is the mainstay of treatment and an important step in preventing AKI is its timely recognition. Current diagnostic methods based on serum creatinine, oliguria, or even novel biomarkers, however, take hours to days to become diagnostic. The investigators have no accepted standard for diagnosing kidney hypoxia in real-time before the injury becomes irreversible. Most clinicians base intraoperative hemodynamic goals for the kidney on "educated guesses" of adequate renal perfusion, since the exact cardiac output or mean arterial pressure targets for preventing AKI are unknown. Even the practice of monitoring urine output is uncertain because of its non-specific relationship to kidney function.18-20 Near infrared spectroscopy (NIRS) is a promising technology for monitoring tissue hypoxia because it is noninvasive and has a long history of clinical use as a monitor of cerebral oximetry in both cardiac and vascular surgery. Because NIRS measures a mixture of arterial and venous capillary oxygenation, it is particularly well-suited to monitor the balance between oxygen consumption and delivery. A large body of literature describes the use of NIRS both as a systemic perfusion monitor and a regional monitor of kidney perfusion in neonates and small children.21-26 In adult cardiac surgery patients, two studies using ultrasound guided placement of NIRS sensors over the kidney found that intraoperative regional tissue oxygen desaturations were associated with the subsequent development of AKI.27, 28 A third study found a correlation between NIRS oxygen saturation measurements over the kidney and renal venous oxygen saturation in adult cardiac surgery patients.29 The problem with these studies, however, is that they excluded patients for body mass index (BMI) greater than 30kg/m2 or if the surface of their kidney was greater than 4cm from the skin. According to the Center for Disease Control, the incidence of obesity (BMI greater than 30kg/m2) is over 40% in the United States and obese patients having cardiac surgery are at increased risk for AKI.30, 31 Thus, if NIRS placed over the kidney in adult patients is to be an effective tool in monitoring kidney hypoxia in adults in the United States, then the technology must be effective in all adult patients.
The major limitation to the use of NIRS for renal hypoxia monitoring in adults is the depth of penetration of the signal. Manufacturers guidelines suggest that the maximum depth of penetration of NIRS is 2.5 cm. The actual depth of penetration of NIRS measurements depends on the source-detector separation, the specific algorithm used, and the optical properties of the tissue being measured. When NIRS is modeled experimentally, there is a nonlinear relationship between source-detector separation and depth of penetration such that a source-detector separation of 20 mm resulted in a depth of penetration of 10 mm but a source-detector separation of 40mm resulted in a depth of penetration of 15mm.32 While in very thin adults, the surface of the kidney may be within 2 cm from the skin, the renal medulla (where most AKI is thought to occur) is several centimeters deeper and thus unlikely to be monitored accurately.
The question then arises as to how these adult cardiac surgery studies showed a relationship between NIRS placed over the kidney, AKI outcome, and even renal venous oxygen saturation.27-29 The lab developed a porcine model in which the investigators directly compared kidney medullary oxygen concentration to NIRS measurements placed over the kidney and the thigh during hemorrhagic shock and aortic occlusion.33 The investigators found during extreme hemodynamic changes such as aortic occlusion, there was a moderate correlation between NIRS and invasive kidney tissue oxygen concentration, but this was true irrespective of whether the NIRS sensors were placed over the kidney or over the thigh. The relationship between kidney NIRS and thigh NIRS was stronger than that with kidney oxygen concentration. This was in animals with kidney surface to skin distances of less than 2 cm. Taken together, these data suggest that renal NIRS in adults may be measuring subcutaneous tissue oxygenation but that it is still a global perfusion monitor that may predict poor global perfusion and AKI risk. Indeed, a study in adult cardiac surgery patients showed that NIRS sensors placed over the thigh predicted subsequent AKI with receiver operator characteristic analysis suggesting an optimal cut-off of 67% and an area under the curve of 0.84.34 The purpose of the current study proposal is to directly compare NIRS placed over the kidney to NIRS placed over the arm or the thigh in adult patients having cardiac surgery at risk for AKI. The hypothesis is that limb NIRS and kidney NIRS will both predict AKI and that the ability of NIRS to predict AKI in adult cardiac surgery patients will be independent of BMI and kidney surface to skin distance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adult cardiac surgery patients undergoing cardiopulmonary bypass surgery at risk for AKI
We will enroll a convenience sample of adult cardiac surgery patients undergoing procedures that require cardiopulmonary bypass (CPB) and who are at risk for AKI.
NIRS sensor placement
After written informed consent, the patient will be brought to the operating room. Skin tone will be assessed using the Monk scale. Prior to induction of general anesthesia, the right kidney will be located by surface ultrasound, the distance between the renal capsule and the skin will be measured, and a NIRS sensor will be placed on the skin overlaying the kidney. If the patient has had a right nephrectomy, the left kidney will be used. Additional NIRS sensors will then be placed over the patient's ipsilateral biceps and vastus lateralis muscles. The distance from the skin to the muscle tissue will be measured and recorded using ultrasound. NIRS sensors will also be placed on the patient's forehead to measure cerebral oximetry as is current practice at our institution for all cardiac surgeries requiring cardiopulmonary bypass.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NIRS sensor placement
After written informed consent, the patient will be brought to the operating room. Skin tone will be assessed using the Monk scale. Prior to induction of general anesthesia, the right kidney will be located by surface ultrasound, the distance between the renal capsule and the skin will be measured, and a NIRS sensor will be placed on the skin overlaying the kidney. If the patient has had a right nephrectomy, the left kidney will be used. Additional NIRS sensors will then be placed over the patient's ipsilateral biceps and vastus lateralis muscles. The distance from the skin to the muscle tissue will be measured and recorded using ultrasound. NIRS sensors will also be placed on the patient's forehead to measure cerebral oximetry as is current practice at our institution for all cardiac surgeries requiring cardiopulmonary bypass.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Utah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Natalie Silverton
Associate Professor of Anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Natalie Silverton, MD
Role: PRINCIPAL_INVESTIGATOR
University of Utah
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Utah
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00179157
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.